OXYTROL

LOE Approaching

oxybutynin

NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Feb 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
13

Mechanism of Action

Cholinergic Muscarinic Antagonists

Pharmacologic Class:

Cholinergic Muscarinic Antagonist

Clinical Trials (5)

NCT04600336Phase 2Completed

Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

Started Oct 2021
88 enrolled
Prostate Carcinoma
NCT02961790Phase 3Completed

Oxybutynin Chloride in Managing Hot Flashes

Started Dec 2016
150 enrolled
Breast CarcinomaDuctal Breast Carcinoma In SituHot Flashes+2 more
NCT02240459Phase 2Completed

A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment

Started Aug 2016
47 enrolled
Overactive BladderMild Cognitive Impairment
NCT02327936Phase 3Completed

Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children

Started Dec 2014
62 enrolled
Overactive Bladder
NCT01192568Phase 4Completed

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Started May 2011
52 enrolled
Overactive DetrusorNeurogenic Bladder